J. Je

Systemic armed oncolytic and immunologic therapy for cancer with JX-594, a targeted poxvirus expressing GM-CSF.

Jiwon Kim, D. Kirn, S. Thorne, 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans

Aaron Fenster, James Burke, Andrew R. Haas, 2011, Nature.